NUCLEOLAR ORGANIZER REGIONS (AGNOR) AND KI-67 IMMUNOREACTIVITY IN CUTANEOUS MELANOCYTIC LESIONS

被引:32
|
作者
FOGT, F
VORTMEYER, AO
TAHAN, SR
机构
[1] NEW ENGLAND DEACONESS HOSP,DEPT PATHOL,BOSTON,MA 02215
[2] BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA
[3] HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA
关键词
DYSPLASTIC NEVUS; MELANOCYTIC LESIONS; MELANOMA; AGNOR; NUCLEOLAR ORGANIZER REGION; KI-67; MIB-1;
D O I
10.1097/00000372-199502000-00003
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A stepwise schema for the developmental biology of malignant melanomas has been proposed. In this study, two properties associated with malignant transformation-AgNOR production and Ki-67 immunoreactivity-were tested on a series of lesions representative of this model. Fourteen ordinary nevi (N), seven dysplastic nevi (DN), 12 radial growth phase melanomas (RGPM), and eight vertical growth phase melanomas (VGPM) were stained for AgNORs; Ki-67 immunoreactivity was determined in paraffin sections after antigen retrieval. AgNORs averaged 2.1 in N, 3.8 in DN, 5.4 in RGPM, and 7.3 in VGPM (p < 0.001 between all groups), Ki-67 immunoreactivity averaged <1 in nevi, 1.6 in dysplastic nevi, 23.3 in RGPM, and 20.1 in VGPM. No difference was observed between N and DN, and RGPM/VGPM had higher Ki-67 indices than N/DN (p < 0.01). Stepwise increases in cellular AgNORs parallel the melanocytic progression model and thereby corroborate the intermediate nature of the dysplastic nevus. The order of magnitude increase in Ki-67 immunoreactivity observed in RGP and VGP melanomas compared with N and DN likely reflects the onset of loss of cell cycle control in these lesions.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [41] PCNA/AgNOR and Ki-67/AgNOR double staining in oral squamous cell carcinoma
    Costa, ADL
    de Araújo, NS
    Pinto, DD
    de Araújo, VC
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1999, 28 (10) : 438 - 441
  • [42] Ki-67 immunoreactivity in meningiomas - Determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67
    Madsen, C
    Schroder, HD
    CLINICAL NEUROPATHOLOGY, 1997, 16 (03) : 137 - 142
  • [43] NUCLEOLAR ORGANIZER REGIONS IN CUTANEOUS T CELL LYMPHOMAS
    许良中
    陈红莉
    邱丙森
    陶玲娣
    ChineseJournalofCancerResearch, 1990, (03) : 61 - 64
  • [45] Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct
    Suto, T
    Sugai, T
    Nakamura, S
    Funato, O
    Nitta, H
    Sasaki, R
    Kanno, S
    Saito, K
    CANCER, 1998, 82 (01) : 86 - 95
  • [46] Expression of Ki-67, PCNA, p-53, and HMB-45 in melanocytic lesions
    Moniem, H
    Choi, YJ
    Niedt, W
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (03): : 11 - 17
  • [47] PROLIFERATING CELL NUCLEAR ANTIGEN, KI-67, C-MYC P62 ONCOPROTEIN, AND NUCLEOLAR ORGANIZER REGIONS IN HODGKINS-DISEASE
    TSENGA, A
    KORKOLOPOULOU, P
    PATSOURIS, E
    PANGALIS, GA
    OATES, J
    SKOPELITOU, A
    ELEMENOGLOU, J
    KITTAS, C
    APPLIED IMMUNOHISTOCHEMISTRY, 1994, 2 (03): : 191 - 196
  • [48] SILVER STAINING OF NUCLEOLAR ORGANIZER REGIONS IN PROSTATIC LESIONS
    GHAZIZADEH, M
    SASAKI, Y
    OGURO, T
    AIHARA, K
    HISTOPATHOLOGY, 1991, 19 (04) : 369 - 372
  • [49] NUCLEOLAR ORGANIZER REGIONS IN CARDIAC LESIONS INDUCED BY DOXORUBICIN
    LEBLANC, B
    MOMPON, PR
    ESPERANDIEU, O
    GEFFRAY, B
    GUILLERMO, C
    TOXICOLOGIC PATHOLOGY, 1991, 19 (02) : 176 - 183
  • [50] NUCLEOLAR ORGANIZER REGIONS IN PRECANCEROUS AND CANCEROUS LESIONS OF THE BRONCHUS
    ABE, S
    OGURA, S
    KUNIKANE, H
    SUKO, N
    WATANABE, N
    NAKAJIMA, I
    KAWAKAMI, Y
    INOUE, K
    CANCER, 1991, 67 (02) : 472 - 475